Old Web
English
Sign In
Acemap
>
Paper
>
Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
2021
Ibon Gurruchaga-Sotes
Carmen Santander-Lobera
Keywords:
cell cancer
Axitinib
Pembrolizumab
Medicine
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]